Get the Answers you need with Candida auris Testing
Candida auris is an emerging fungal disease that it is often resistant to antifungal drugs. This, makes it difficult to treat and makes it a major public health threat.
Although it can infect anyone, it poses a special hazard to people with compromised immune systems. In these people, it can result in death.
C. auris is easily spread within healthcare facilities, particularly those in which older people are in residence for prolonged periods. It can go undetected in most healthy people, which means that they may be actively spreading it without being aware of it.
To determine if it exists within long-term care facilities, it is essential that residents and employees, whether symptomatic or not, be tested. If C. auris is detected, follow-up testing will be essential to determine if it has been eradicated from the facilities.
Testing is painless. A cotton swab will be used to wipe the skin in areas such as armpits and groin that are most susceptible to infection. The swab will then be sent to the laboratory for testing.
Frequently Asked Questions
Have a question about Soft Cell Candida auris testing, or curious about other information? Feel free to browse the FAQ section below or to give us a call: We would love to help!
What is Candida auris?
Candida auris is a type of yeast that can cause serious infections in humans.
Is Candida auris contagious?
Yes, Candida auris is contagious and can spread from person to person, particularly in healthcare settings. However, it is not highly contagious like some other infections, such as COVID or the flu, that are spread through the air.
How is Candida auris spread?
Candida auris is most commonly spread in healthcare settings, such as hospitals and nursing homes. It can be spread from person to person through contact with
contaminated surfaces or equipment, or through direct contact with an infected person.
Is Candida auris a new infection?
Yes, Candida auris was first identified in 2009 in Japan, and since then, it has been reported in many countries around the world. It has been detected in 28 states within the United States, with California, Nevada, Texas, Illinois, New York, and Florida being “hot spots.”
What are the symptoms?
Symptoms of Candida auris infections can vary depending on the location of the infection and the health status of the patient. They can include fever, chills, and fatigue.
How is Candida auris treated?
Candida auris is often resistant to multiple anti-fungal drugs, which makes it difficult to treat. Treatment may involve the use of high-dose anti-fungal medications and may require hospitalization. Left untreated, it can lead to death among immunocompromised patients.
How can Candida auris infections be prevented?
Prevention and control measures for Candida auris infections include strict infection control practices in healthcare settings, such as hand hygiene, using personal protective equipment (PPE), and isolating infected patients. It is also important to use appropriate anti-fungal treatment for infected patients and to closely monitor and track cases to detect and contain outbreaks.